Index S&P 500
P/E 73.23
EPS (ttm) 0.36
Insider Own 0.04%
Shs Outstand 5.65B
Perf Week 2.45%
Market Cap 148.62B
Forward P/E 9.63
EPS next Y 2.73
Insider Trans 0.13%
Shs Float 5.64B
Perf Month -3.80%
Income 2.13B
PEG -
EPS next Q 0.53
Inst Own 70.07%
Short Float 1.15%
Perf Quarter -7.42%
Sales 58.50B
P/S 2.54
EPS this Y 20.03%
Inst Trans 0.52%
Short Ratio 1.52
Perf Half Y -14.13%
Book/sh 15.77
P/B 1.67
EPS next Y 23.81%
ROA 1.01%
Short Interest 65.00M
Perf Year -34.54%
Cash/sh 2.25
P/C 11.71
EPS next 5Y -1.33%
ROE 2.31%
52W Range 25.23 - 40.37
Perf YTD -8.58%
Dividend Est. 1.70 (6.45% )
P/FCF 31.01
EPS past 5Y -27.43%
ROI 1.39%
52W High -34.79%
Beta 0.61
Dividend TTM 1.65 (6.27% )
Quick Ratio 0.69
Sales past 5Y 10.96%
Gross Margin 48.99%
52W Low 4.32%
ATR (14) 0.47
Dividend Ex-Date Jan 25, 2024
Current Ratio 0.91
EPS Y/Y TTM -93.20%
Oper. Margin 6.16%
RSI (14) 45.36
Volatility 1.69% 1.62%
Employees 88000
Debt/Eq 0.84
Sales Y/Y TTM -41.70%
Profit Margin 3.65%
Recom 2.27
Target Price 31.22
Option/Short Yes / Yes
LT Debt/Eq 0.72
EPS Q/Q -168.11%
Payout 439.41%
Rel Volume 0.56
Prev Close 26.26
Sales Surprise -0.84%
EPS Surprise 163.21%
Sales Q/Q -41.34%
Earnings May 01 BMO
Avg Volume 42.74M
Price 26.32
SMA20 -1.22%
SMA50 -2.81%
SMA200 -14.25%
Trades
Volume 23,818,286
Change 0.23%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-22-24 Downgrade
Argus
Buy → Hold
Feb-23-24 Initiated
Guggenheim
Buy
$36
Jan-04-24 Downgrade
TD Cowen
Outperform → Market Perform
$32
Oct-20-23 Resumed
UBS
Neutral
$36 → $34
Oct-16-23 Upgrade
Jefferies
Hold → Buy
$38 → $39
Jul-17-23 Reiterated
JP Morgan
Neutral
$45 → $41
Jul-14-23 Initiated
HSBC Securities
Buy
$50
Jun-29-23 Downgrade
Credit Suisse
Outperform → Neutral
$47 → $40
May-11-23 Downgrade
Daiwa Securities
Outperform → Neutral
$38
Mar-06-23 Initiated
Jefferies
Hold
$43
Feb-07-23 Upgrade
Daiwa Securities
Neutral → Outperform
$51
Jan-26-23 Downgrade
UBS
Buy → Neutral
$55 → $47
Jan-17-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$54 → $50
Jan-04-23 Downgrade
BofA Securities
Buy → Neutral
$60
Dec-13-22 Upgrade
Goldman
Neutral → Buy
$47 → $60
Nov-18-22 Initiated
Credit Suisse
Outperform
$55
May-23-22 Initiated
SVB Leerink
Mkt Perform
$55
Apr-06-22 Resumed
Morgan Stanley
Equal-Weight
$55
Jan-05-22 Upgrade
BofA Securities
Neutral → Buy
$59 → $70
Jan-03-22 Reiterated
Bernstein
Mkt Perform
$44 → $65
Show Previous Ratings
Apr-23-24 09:15AM
07:21AM
Apr-22-24 06:08PM
05:45PM
11:10AM
08:08AM
Loading…
08:08AM
Apr-21-24 10:43AM
10:39AM
Apr-20-24 05:50AM
Apr-19-24 02:05PM
09:00AM
Apr-18-24 11:44AM
(Investor's Business Daily)
09:54AM
09:15AM
Apr-17-24 06:39AM
06:00AM
Loading…
06:00AM
05:21AM
Apr-16-24 11:36PM
01:49PM
05:05AM
Apr-15-24 05:45PM
08:45AM
04:53AM
Apr-14-24 03:00PM
03:00AM
Apr-13-24 12:18PM
10:00AM
(The Wall Street Journal)
05:47AM
Apr-12-24 06:30PM
06:07AM
05:50AM
Loading…
05:50AM
05:00AM
Apr-11-24 10:00AM
09:53AM
09:12AM
Apr-10-24 03:30PM
12:47PM
09:26AM
02:06AM
Apr-09-24 05:14PM
12:49PM
10:54AM
08:15AM
08:10AM
07:02AM
06:47AM
06:45AM
05:50AM
Apr-08-24 05:57PM
05:45PM
12:44PM
09:00AM
05:47AM
05:06AM
Apr-07-24 05:47AM
Apr-06-24 06:49AM
Apr-05-24 02:16PM
06:12AM
Apr-04-24 09:27AM
04:05AM
Apr-02-24 10:22AM
05:21AM
Apr-01-24 05:45PM
02:49PM
10:15AM
07:56AM
05:05AM
Mar-31-24 09:31AM
Mar-30-24 03:52PM
Mar-29-24 11:04PM
Mar-28-24 07:03PM
05:28PM
02:36PM
01:38PM
10:06AM
Mar-27-24 09:25AM
09:00AM
08:20AM
04:50AM
Mar-26-24 05:12PM
02:47PM
08:36AM
06:18AM
06:18AM
04:17AM
Mar-25-24 05:45PM
09:48AM
06:47AM
06:25AM
05:51AM
04:50AM
Mar-24-24 10:42AM
Mar-23-24 06:45AM
05:50AM
05:43AM
04:30AM
Mar-22-24 10:07PM
Mar-21-24 03:30PM
11:38AM
11:31AM
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
BOURLA ALBERT Chairman & CEO Feb 23 '24 Option Exercise 27.34 127,674 3,490,607 439,748 Feb 27 01:46 PM LANKLER DOUGLAS M Executive Vice President Feb 23 '24 Option Exercise 27.34 95,755 2,617,942 230,920 Feb 27 01:46 PM SUSMAN SALLY Executive Vice President Feb 23 '24 Option Exercise 27.34 63,837 1,745,304 218,148 Feb 27 01:46 PM JOHNSON RADY A Executive Vice President Feb 23 '24 Option Exercise 27.34 29,436 804,780 123,073 Feb 27 01:46 PM McDermott Michael Executive Vice President Feb 23 '24 Option Exercise 27.34 12,412 339,344 95,408 Feb 27 01:47 PM SAHNI PAYAL Executive Vice President Feb 23 '24 Option Exercise 27.34 11,527 315,148 34,604 Feb 27 01:46 PM DAMICO JENNIFER B. SVP & Controller Feb 23 '24 Option Exercise 27.34 9,752 266,620 19,228 Feb 27 01:46 PM BOSHOFF CHRISTOFFEL Executive Vice President Feb 23 '24 Option Exercise 27.34 9,752 266,620 148,703 Feb 27 01:44 PM Gottlieb Scott Director Dec 15 '23 Buy 26.47 3,000 79,401 9,000 Dec 19 09:31 AM Gottlieb Scott Director May 08 '23 Buy 38.58 1,000 38,580 6,000 May 09 04:17 PM Gottlieb Scott Director May 05 '23 Buy 38.42 1,000 38,425 5,000 May 09 04:17 PM
Index S&P 500
P/E 23.08
EPS (ttm) 3.02
Insider Own 0.45%
Shs Outstand 157.61M
Perf Week -0.16%
Market Cap 10.97B
Forward P/E 18.40
EPS next Y 3.79
Insider Trans -17.64%
Shs Float 156.67M
Perf Month -18.52%
Income 479.20M
PEG 1.40
EPS next Q 0.98
Inst Own 108.57%
Short Float 12.21%
Perf Quarter 0.68%
Sales 26.54B
P/S 0.41
EPS this Y 4.02%
Inst Trans 1.51%
Short Ratio 9.53
Perf Half Y 10.90%
Book/sh 38.54
P/B 1.81
EPS next Y 20.56%
ROA 1.77%
Short Interest 19.12M
Perf Year 0.77%
Cash/sh 6.87
P/C 10.15
EPS next 5Y 16.50%
ROE 8.20%
52W Range 59.66 - 88.22
Perf YTD -9.19%
Dividend Est. -
P/FCF -
EPS past 5Y -8.81%
ROI 1.94%
52W High -21.00%
Beta 1.64
Dividend TTM -
Quick Ratio 0.67
Sales past 5Y 11.17%
Gross Margin 9.26%
52W Low 16.81%
ATR (14) 2.38
Dividend Ex-Date -
Current Ratio 2.26
EPS Y/Y TTM -0.41%
Oper. Margin -0.46%
RSI (14) 33.55
Volatility 2.33% 2.66%
Employees 29836
Debt/Eq 3.22
Sales Y/Y TTM -10.61%
Profit Margin 1.81%
Recom 2.29
Target Price 77.56
Option/Short Yes / Yes
LT Debt/Eq 3.07
EPS Q/Q -27.05%
Payout 0.00%
Rel Volume 0.78
Prev Close 67.88
Sales Surprise -2.72%
EPS Surprise -30.51%
Sales Q/Q -1.68%
Earnings Apr 11 BMO
Avg Volume 2.01M
Price 69.69
SMA20 -10.77%
SMA50 -10.77%
SMA200 -6.95%
Trades
Volume 1,563,105
Change 2.67%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-20-24 Upgrade
Needham
Hold → Buy
$99
Mar-19-24 Initiated
Mizuho
Neutral
$80
Sep-25-23 Upgrade
Wedbush
Neutral → Outperform
$85 → $90
Jun-12-23 Downgrade
Northcoast
Buy → Neutral
Feb-23-23 Resumed
Truist
Hold
$66
Jan-11-23 Downgrade
JP Morgan
Neutral → Underweight
$60
Jan-05-23 Downgrade
Argus
Buy → Hold
Dec-23-22 Reiterated
Oppenheimer
Outperform
$100 → $75
Oct-03-22 Downgrade
Stephens
Overweight → Equal-Weight
$105 → $64
Sep-09-22 Downgrade
BofA Securities
Neutral → Underperform
$146 → $100
May-02-22 Initiated
Needham
Hold
Apr-13-22 Downgrade
JP Morgan
Overweight → Neutral
$130 → $110
Apr-06-22 Downgrade
BofA Securities
Buy → Neutral
$195 → $165
Feb-16-22 Downgrade
Evercore ISI
Outperform → In-line
$120
Jan-28-22 Resumed
RBC Capital Mkts
Outperform
$157 → $140
Jan-27-22 Upgrade
Seaport Research Partners
Neutral → Buy
$140
Dec-07-21 Upgrade
JP Morgan
Neutral → Overweight
$140 → $160
Oct-01-21 Resumed
Wolfe Research
Outperform
$160
Oct-01-21 Downgrade
Guggenheim
Buy → Neutral
May-19-21 Downgrade
Wedbush
Outperform → Neutral
$155 → $130
Show Previous Ratings
Apr-23-24 03:01AM
Apr-22-24 10:00AM
Apr-18-24 08:48AM
Apr-16-24 09:46AM
01:01AM
04:06AM
Loading…
Apr-15-24 04:06AM
Apr-12-24 11:26AM
03:03AM
12:47AM
(Thomson Reuters StreetEvents)
Apr-11-24 05:28PM
04:43PM
04:43PM
04:00PM
03:35PM
02:30PM
02:18PM
Loading…
02:18PM
01:54PM
01:45PM
01:07PM
12:41PM
12:27PM
12:25PM
(Associated Press Finance)
12:08PM
11:58AM
11:56AM
11:52AM
11:52AM
(The Wall Street Journal)
11:31AM
11:15AM
(The Wall Street Journal)
10:40AM
10:10AM
Loading…
10:10AM
09:47AM
09:43AM
09:30AM
07:21AM
07:04AM
(Associated Press Finance)
07:02AM
06:59AM
06:53AM
06:50AM
Apr-10-24 05:25PM
03:00AM
Apr-08-24 09:56AM
09:15AM
Apr-07-24 07:00AM
Apr-05-24 11:10AM
05:48AM
Apr-04-24 10:00AM
Apr-02-24 04:28AM
Apr-01-24 07:21AM
Mar-30-24 07:07AM
Mar-29-24 08:39AM
Mar-27-24 08:38AM
Mar-26-24 08:11AM
Mar-22-24 06:58PM
05:09PM
Mar-21-24 02:20PM
Mar-20-24 05:00PM
01:26PM
10:06AM
09:57AM
09:12AM
08:52AM
Mar-18-24 10:01PM
(Thomson Reuters StreetEvents)
Feb-29-24 01:20AM
Feb-27-24 10:15AM
06:00AM
(The Wall Street Journal)
Feb-21-24 02:34PM
Feb-14-24 07:01AM
Jan-31-24 02:01AM
02:01AM
Jan-29-24 11:02PM
Jan-24-24 11:02PM
Jan-23-24 06:39AM
Jan-19-24 12:14AM
Jan-16-24 06:13AM
Jan-06-24 06:02AM
Dec-30-23 11:01AM
08:15AM
Dec-29-23 06:30PM
Dec-23-23 10:43AM
Dec-22-23 02:00PM
09:23AM
12:36AM
(Thomson Reuters StreetEvents)
Dec-21-23 05:25PM
04:55PM
04:38PM
04:09PM
04:01PM
12:20PM
12:20PM
12:20PM
12:18PM
12:09PM
12:03PM
12:00PM
(The Wall Street Journal)
11:00AM
10:33AM
10:03AM
(The Wall Street Journal)
09:36AM
CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Livesay Jill A VP, Controller & PAO Jan 29 '24 Option Exercise 58.38 14,199 828,938 23,267 Jan 30 04:14 PM Livesay Jill A VP, Controller & PAO Jan 29 '24 Sale 70.89 14,199 1,006,567 9,068 Jan 30 04:14 PM Cafritz Diane L EVP, General Counsel & CCO Jan 26 '24 Option Exercise 63.04 22,000 1,386,880 27,073 Jan 29 04:37 PM Cafritz Diane L EVP, General Counsel & CCO Jan 26 '24 Sale 70.08 22,000 1,541,760 5,073 Jan 29 04:37 PM Cafritz Diane L EVP, General Counsel & CCO Jan 23 '24 Option Exercise 63.04 2,730 172,099 7,803 Jan 24 04:17 PM Cafritz Diane L EVP, General Counsel & CCO Jan 23 '24 Sale 70.54 2,730 192,574 5,073 Jan 24 04:17 PM Daniels Jon G SVP, CAF Dec 27 '23 Option Exercise 58.38 10,000 583,800 11,525 Dec 28 04:28 PM Daniels Jon G SVP, CAF Dec 27 '23 Sale 77.56 10,000 775,600 1,525 Dec 28 04:28 PM Nash William D President & CEO Dec 26 '23 Option Exercise 58.38 102,775 6,000,004 279,955 Dec 28 04:28 PM Nash William D President & CEO Dec 26 '23 Sale 75.09 102,775 7,717,375 177,180 Dec 28 04:28 PM Daniels Jon G SVP, CAF Jul 20 '23 Option Exercise 58.38 7,783 454,372 9,308 Jul 24 04:11 PM Daniels Jon G SVP, CAF Jul 20 '23 Sale 85.25 7,783 663,501 1,525 Jul 24 04:11 PM Lyski James EVP & Chief Marketing Officer Jul 12 '23 Option Exercise 58.38 67,345 3,931,601 89,131 Jul 13 04:13 PM Newberry Darren C SVP Jul 12 '23 Option Exercise 58.91 6,254 368,396 20,024 Jul 13 04:11 PM Lyski James EVP & Chief Marketing Officer Jul 12 '23 Sale 84.27 67,345 5,675,163 21,786 Jul 13 04:13 PM Newberry Darren C SVP Jul 12 '23 Sale 84.56 9,607 812,368 10,417 Jul 13 04:11 PM Daniels Jon G SVP, CAF Jul 11 '23 Option Exercise 58.38 10,000 583,800 17,255 Jul 12 04:10 PM Daniels Jon G SVP, CAF Jul 11 '23 Sale 84.59 15,730 1,330,531 1,525 Jul 12 04:10 PM Nash William D President & CEO Jul 03 '23 Option Exercise 57.25 170,646 9,768,839 347,826 Jul 05 05:56 PM Nash William D President & CEO Jul 03 '23 Sale 82.57 170,646 14,090,500 177,180 Jul 05 05:56 PM Daniels Jon G SVP, CAF Jun 28 '23 Option Exercise 58.38 27,783 1,621,972 35,038 Jun 30 04:20 PM Shamim Mohammad EVP and CITO Jun 28 '23 Option Exercise 58.38 27,782 1,621,913 38,674 Jun 30 04:18 PM Livesay Jill A VP, Controller & PAO Jun 28 '23 Option Exercise 58.38 14,000 817,320 23,068 Jun 30 04:19 PM Shamim Mohammad EVP and CITO Jun 28 '23 Sale 83.82 27,782 2,328,758 10,892 Jun 30 04:18 PM Daniels Jon G SVP, CAF Jun 28 '23 Sale 82.42 27,783 2,289,875 7,255 Jun 30 04:20 PM Livesay Jill A VP, Controller & PAO Jun 28 '23 Sale 84.50 14,000 1,183,000 9,068 Jun 30 04:19 PM Cafritz Diane L EVP, General Counsel & CHRO Jun 28 '23 Sale 83.85 1,706 143,048 5,073 Jun 30 04:21 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite